|
Books > Medicine > Other branches of medicine > Anaesthetics > Pain & pain management
The European Pain Federation EFIC is made up of Chapters of the
International Association for the Study of Pain (IASP). Its Health
Care Professionals look after a population of over 740 million
people in its 37 member countries. European Pain Management
provides a review of the organization and delivery of pain care in
the 37 European countries. Leaders in the field of pain management
from each country offer a chapter on how their health and pain care
services are organized, the demands of their specific populations,
the specific national challenges they face, and examples of
innovations and advances. After this comprehensive summary, key
experts in the field discuss issues that are pertinent to all the
European nations; ranging from working with young people to
managing opioids, and the rise of pain as a specialism. The final
chapter pulls together themes from across the entire book, making a
call to envision a new form of pain management for a new Europe.
European Pain Management provides an authoritative summary,
description, and discussion of the challenges and opportunities for
improving the care of people living in pain.
Veronika Schneider gibt in diesem essential in Kurzform AErzten
aller Fachgebiete einen UEberblick uber Ursachen, Symptomatik,
Diagnostik, Differenzialdiagnosen und Therapie des
Restless-Legs-Syndroms - auch bekannt als Willis-Ekbom-Disease oder
Wittmaack-Ekbom-Syndrom. Damit bietet die Autorin eine
Hilfestellung bei der Diagnosestellung und gibt eine UEbersicht
uber die Therapiemoeglichkeiten und ihre Nebenwirkungen.
Part memoir, part history, part journalistic expose, Trip is a look
at psychedelic drugs, literature, and alienation from one of the
twenty-first century's most innovative novelists--The Electric
Kool-Aid Acid Test for a new generation. A Vintage Original. While
reeling from one of the most creative--but at times
self-destructive--outpourings of his life, Tao Lin discovered the
strange and exciting work of Terence McKenna. McKenna, the leading
advocate of psychedelic drugs since Timothy Leary, became for Lin
both an obsession and a revitalizing force. In Trip, Lin's first
book-length work of nonfiction, he charts his recovery from
pharmaceutical drugs, his surprising and positive change in
worldview, and his four-year engagement with some of the hardest
questions: Why do we make art? Is the world made of language? What
happens when we die? And is the imagination more real than the
universe? In exploring these ideas and detailing his experiences
with psilocybin, DMT, salvia, and cannabis, Lin takes readers on a
trip through nature, his own past, psychedelic culture, and the
unknown.
As our understanding of the mechanisms of the brain and nervous
system that underlie the conscious experience of pain has increased
over the past 60 years, so too has the field of pain management.
What began as almost exclusively the domain of anaesthetists has
become multidisciplinary, and now comprises many other specialisms
including neurology, psychology, nursing, occupational therapy and
physiotherapy. This spate of activity has been paralleled by a
similar growth in research: in neurophysiology, psychology and
pharmacology as well as clinical medicine. Simultaneously, the
pharmaceutical industry has spent billions of pounds and dollars in
the search for better drugs for relieving pain. This
ground-breaking book is compiled by former contributors to The
Special Interest Group for Philosophy and Ethics of the British
Pain Society. The issues discussed include satisfactory relief of
chronic pain, the inadequacy of scientific biomedicine in offering
answers, and ethical problems arising in pain medicine. 'Suffering
cannot be found in a laboratory test or imaging study; it is only
observable by communicating with the sufferer. The eleven chapters
in this book approach this conundrum from vastly different
perspectives, some highly personal and others broadly social.
Issues such as the interface between the physician and the
pharmaceutical industry are also presented. Each chapter describes
a facet of the problems of suffering and some of the available
paths to recovery.' John D Loeser in the Foreword
|
|